Which has better valuation and earnings, OWLT or BWAY?

Brainsway has lower revenue, but higher earnings than Owlet. Owlet is trading at a lower price-to-earnings ratio than Brainsway, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Owlet $105.70M 1.45 -$39.68M -$0.75 N/A Brainsway $52.22M 11.33 $7.57M $0.44 33.50

Is OWLT or BWAY more profitable?

Brainsway has a net margin of 15.65% compared to Owlet's net margin of -8.61%. Brainsway's return on equity of 12.74% beat Owlet's return on equity. Company Net Margins Return on Equity Return on Assets Owlet -8.61% -601.24% -15.96% Brainsway 15.65% 12.74% 8.17%

Does the media prefer OWLT or BWAY?

In the previous week, Owlet had 2 more articles in the media than Brainsway. MarketBeat recorded 4 mentions for Owlet and 2 mentions for Brainsway. Owlet's average media sentiment score of 0.86 beat Brainsway's score of 0.56 indicating that Owlet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Owlet 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Brainsway 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings and valuation, KIDS or OWLT?

OrthoPediatrics has higher revenue and earnings than Owlet. OrthoPediatrics is trading at a lower price-to-earnings ratio than Owlet, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio OrthoPediatrics $236.35M 2.83 -$39.65M -$1.68 N/A Owlet $105.70M 1.45 -$39.68M -$0.75 N/A

Is KIDS or OWLT more profitable?

Owlet has a net margin of -8.61% compared to OrthoPediatrics' net margin of -15.72%. OrthoPediatrics' return on equity of -8.10% beat Owlet's return on equity. Company Net Margins Return on Equity Return on Assets OrthoPediatrics -15.72% -8.10% -5.54% Owlet -8.61% -601.24% -15.96%

Does the media refer more to KIDS or OWLT?

In the previous week, OrthoPediatrics had 3 more articles in the media than Owlet. MarketBeat recorded 7 mentions for OrthoPediatrics and 4 mentions for Owlet. Owlet's average media sentiment score of 0.86 beat OrthoPediatrics' score of 0.75 indicating that Owlet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OrthoPediatrics 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Owlet 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation and earnings, DCTH or OWLT?

Delcath Systems has higher earnings, but lower revenue than Owlet. Owlet is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Delcath Systems $85.23M 6.98 $2.70M $0.01 1,714.00 Owlet $105.70M 1.45 -$39.68M -$0.75 N/A

Is DCTH or OWLT more profitable?

Delcath Systems has a net margin of 0.56% compared to Owlet's net margin of -8.61%. Delcath Systems' return on equity of 0.46% beat Owlet's return on equity. Company Net Margins Return on Equity Return on Assets Delcath Systems 0.56% 0.46% 0.42% Owlet -8.61% -601.24% -15.96%

Which has higher valuation and earnings, NPCE or OWLT?

NeuroPace has higher earnings, but lower revenue than Owlet. NeuroPace is trading at a lower price-to-earnings ratio than Owlet, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio NeuroPace $99.99M 4.82 -$21.47M -$0.57 N/A Owlet $105.70M 1.45 -$39.68M -$0.75 N/A

Is NPCE or OWLT more profitable?

Owlet has a net margin of -8.61% compared to NeuroPace's net margin of -19.34%. NeuroPace's return on equity of -105.64% beat Owlet's return on equity. Company Net Margins Return on Equity Return on Assets NeuroPace -19.34% -105.64% -16.51% Owlet -8.61% -601.24% -15.96%

Does the media prefer NPCE or OWLT?

In the previous week, NeuroPace had 8 more articles in the media than Owlet. MarketBeat recorded 12 mentions for NeuroPace and 4 mentions for Owlet. Owlet's average media sentiment score of 0.86 beat NeuroPace's score of 0.39 indicating that Owlet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NeuroPace 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Owlet 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is OWLT or CLPT more profitable?

Owlet has a net margin of -8.61% compared to ClearPoint Neuro's net margin of -81.76%. ClearPoint Neuro's return on equity of -188.09% beat Owlet's return on equity. Company Net Margins Return on Equity Return on Assets Owlet -8.61% -601.24% -15.96% ClearPoint Neuro -81.76% -188.09% -40.88%

Does the media refer more to OWLT or CLPT?

In the previous week, Owlet had 2 more articles in the media than ClearPoint Neuro. MarketBeat recorded 4 mentions for Owlet and 2 mentions for ClearPoint Neuro. ClearPoint Neuro's average media sentiment score of 1.70 beat Owlet's score of 0.86 indicating that ClearPoint Neuro is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Owlet 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ClearPoint Neuro 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Owlet (OWLT) Competitors

$5.23 -0.35 (-6.27%)

As of 08/21/2026 03:58 PM Eastern

Compare

OWLT vs. BWAY, KIDS, DCTH, NPCE, and CLPT

Should you buy Owlet stock or one of its competitors? Owlet's main competitors and comparable companies include Brainsway (BWAY), OrthoPediatrics (KIDS), Delcath Systems (DCTH), NeuroPace (NPCE), and ClearPoint Neuro (CLPT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Owlet compare to Brainsway?

Owlet (NYSE:OWLT) and Brainsway (NASDAQ:BWAY) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations, media sentiment and risk.

In the previous week, Owlet had 2 more articles in the media than Brainsway. MarketBeat recorded 4 mentions for Owlet and 2 mentions for Brainsway. Owlet's average media sentiment score of 0.86 beat Brainsway's score of 0.56 indicating that Owlet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Owlet	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Brainsway	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

72.6% of Owlet shares are owned by institutional investors. Comparatively, 30.1% of Brainsway shares are owned by institutional investors. 36.2% of Owlet shares are owned by insiders. Comparatively, 19.0% of Brainsway shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Owlet has a beta of 1.85, suggesting that its share price is 85% more volatile than the broader market. Comparatively, Brainsway has a beta of 1.24, suggesting that its share price is 24% more volatile than the broader market.

Brainsway has a net margin of 15.65% compared to Owlet's net margin of -8.61%. Brainsway's return on equity of 12.74% beat Owlet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Owlet	-8.61%	-601.24%	-15.96%
Brainsway	15.65%	12.74%	8.17%

Brainsway has lower revenue, but higher earnings than Owlet. Owlet is trading at a lower price-to-earnings ratio than Brainsway, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Owlet	$105.70M	1.45	-$39.68M	-$0.75	N/A
Brainsway	$52.22M	11.33	$7.57M	$0.44	33.50

Owlet currently has a consensus target price of $15.00, indicating a potential upside of 186.81%. Brainsway has a consensus target price of $16.95, indicating a potential upside of 14.99%. Given Owlet's higher probable upside, equities research analysts clearly believe Owlet is more favorable than Brainsway.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Owlet	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Brainsway	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

Summary

Brainsway beats Owlet on 9 of the 16 factors compared between the two stocks.

How does Owlet compare to OrthoPediatrics?

OrthoPediatrics (NASDAQ:KIDS) and Owlet (NYSE:OWLT) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, media sentiment, dividends, earnings and analyst recommendations.

OrthoPediatrics has higher revenue and earnings than Owlet. OrthoPediatrics is trading at a lower price-to-earnings ratio than Owlet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OrthoPediatrics	$236.35M	2.83	-$39.65M	-$1.68	N/A
Owlet	$105.70M	1.45	-$39.68M	-$0.75	N/A

In the previous week, OrthoPediatrics had 3 more articles in the media than Owlet. MarketBeat recorded 7 mentions for OrthoPediatrics and 4 mentions for Owlet. Owlet's average media sentiment score of 0.86 beat OrthoPediatrics' score of 0.75 indicating that Owlet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OrthoPediatrics	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Owlet	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

69.1% of OrthoPediatrics shares are owned by institutional investors. Comparatively, 72.6% of Owlet shares are owned by institutional investors. 32.5% of OrthoPediatrics shares are owned by insiders. Comparatively, 36.2% of Owlet shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

OrthoPediatrics has a beta of 0.98, meaning that its share price is 2% less volatile than the broader market. Comparatively, Owlet has a beta of 1.85, meaning that its share price is 85% more volatile than the broader market.

OrthoPediatrics presently has a consensus price target of $26.44, suggesting a potential upside of 3.10%. Owlet has a consensus price target of $15.00, suggesting a potential upside of 186.81%. Given Owlet's higher possible upside, analysts plainly believe Owlet is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73
Owlet	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Owlet has a net margin of -8.61% compared to OrthoPediatrics' net margin of -15.72%. OrthoPediatrics' return on equity of -8.10% beat Owlet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OrthoPediatrics	-15.72%	-8.10%	-5.54%
Owlet	-8.61%	-601.24%	-15.96%

Summary

OrthoPediatrics and Owlet tied by winning 8 of the 16 factors compared between the two stocks.

How does Owlet compare to Delcath Systems?

Delcath Systems (NASDAQ:DCTH) and Owlet (NYSE:OWLT) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, media sentiment, dividends, institutional ownership, earnings, analyst recommendations, profitability and valuation.

Delcath Systems has a net margin of 0.56% compared to Owlet's net margin of -8.61%. Delcath Systems' return on equity of 0.46% beat Owlet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Delcath Systems	0.56%	0.46%	0.42%
Owlet	-8.61%	-601.24%	-15.96%

Delcath Systems has a beta of 0.52, meaning that its share price is 48% less volatile than the broader market. Comparatively, Owlet has a beta of 1.85, meaning that its share price is 85% more volatile than the broader market.

In the previous week, Owlet had 4 more articles in the media than Delcath Systems. MarketBeat recorded 4 mentions for Owlet and 0 mentions for Delcath Systems. Owlet's average media sentiment score of 0.86 beat Delcath Systems' score of 0.00 indicating that Owlet is being referred to more favorably in the news media.

Company	Overall Sentiment
Delcath Systems	Neutral
Owlet	Positive

Delcath Systems currently has a consensus price target of $23.17, suggesting a potential upside of 35.16%. Owlet has a consensus price target of $15.00, suggesting a potential upside of 186.81%. Given Owlet's higher probable upside, analysts clearly believe Owlet is more favorable than Delcath Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Delcath Systems	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.86
Owlet	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Delcath Systems has higher earnings, but lower revenue than Owlet. Owlet is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Delcath Systems	$85.23M	6.98	$2.70M	$0.01	1,714.00
Owlet	$105.70M	1.45	-$39.68M	-$0.75	N/A

61.1% of Delcath Systems shares are held by institutional investors. Comparatively, 72.6% of Owlet shares are held by institutional investors. 19.4% of Delcath Systems shares are held by company insiders. Comparatively, 36.2% of Owlet shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Delcath Systems beats Owlet on 10 of the 17 factors compared between the two stocks.

How does Owlet compare to NeuroPace?

NeuroPace (NASDAQ:NPCE) and Owlet (NYSE:OWLT) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, earnings, profitability and analyst recommendations.

78.8% of NeuroPace shares are held by institutional investors. Comparatively, 72.6% of Owlet shares are held by institutional investors. 19.2% of NeuroPace shares are held by company insiders. Comparatively, 36.2% of Owlet shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, NeuroPace had 8 more articles in the media than Owlet. MarketBeat recorded 12 mentions for NeuroPace and 4 mentions for Owlet. Owlet's average media sentiment score of 0.86 beat NeuroPace's score of 0.39 indicating that Owlet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NeuroPace	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Owlet	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

NeuroPace has higher earnings, but lower revenue than Owlet. NeuroPace is trading at a lower price-to-earnings ratio than Owlet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeuroPace	$99.99M	4.82	-$21.47M	-$0.57	N/A
Owlet	$105.70M	1.45	-$39.68M	-$0.75	N/A

NeuroPace currently has a consensus target price of $19.29, suggesting a potential upside of 37.46%. Owlet has a consensus target price of $15.00, suggesting a potential upside of 186.81%. Given Owlet's higher probable upside, analysts plainly believe Owlet is more favorable than NeuroPace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeuroPace	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.78
Owlet	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

NeuroPace has a beta of 1.92, suggesting that its share price is 92% more volatile than the broader market. Comparatively, Owlet has a beta of 1.85, suggesting that its share price is 85% more volatile than the broader market.

Owlet has a net margin of -8.61% compared to NeuroPace's net margin of -19.34%. NeuroPace's return on equity of -105.64% beat Owlet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeuroPace	-19.34%	-105.64%	-16.51%
Owlet	-8.61%	-601.24%	-15.96%

Summary

NeuroPace beats Owlet on 10 of the 17 factors compared between the two stocks.

How does Owlet compare to ClearPoint Neuro?

Owlet (NYSE:OWLT) and ClearPoint Neuro (NASDAQ:CLPT) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations, earnings and media sentiment.

In the previous week, Owlet had 2 more articles in the media than ClearPoint Neuro. MarketBeat recorded 4 mentions for Owlet and 2 mentions for ClearPoint Neuro. ClearPoint Neuro's average media sentiment score of 1.70 beat Owlet's score of 0.86 indicating that ClearPoint Neuro is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Owlet	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
ClearPoint Neuro	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Owlet has a beta of 1.85, meaning that its stock price is 85% more volatile than the broader market. Comparatively, ClearPoint Neuro has a beta of 1.24, meaning that its stock price is 24% more volatile than the broader market.

Owlet presently has a consensus target price of $15.00, suggesting a potential upside of 186.81%. ClearPoint Neuro has a consensus target price of $25.67, suggesting a potential upside of 66.77%. Given Owlet's stronger consensus rating and higher possible upside, research analysts clearly believe Owlet is more favorable than ClearPoint Neuro.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Owlet	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
ClearPoint Neuro	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

ClearPoint Neuro has lower revenue, but higher earnings than Owlet. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Owlet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Owlet	$105.70M	1.45	-$39.68M	-$0.75	N/A
ClearPoint Neuro	$36.97M	12.70	-$25.54M	-$1.18	N/A

72.6% of Owlet shares are owned by institutional investors. Comparatively, 30.1% of ClearPoint Neuro shares are owned by institutional investors. 36.2% of Owlet shares are owned by company insiders. Comparatively, 6.9% of ClearPoint Neuro shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Owlet has a net margin of -8.61% compared to ClearPoint Neuro's net margin of -81.76%. ClearPoint Neuro's return on equity of -188.09% beat Owlet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Owlet	-8.61%	-601.24%	-15.96%
ClearPoint Neuro	-81.76%	-188.09%	-40.88%

Summary

Owlet beats ClearPoint Neuro on 12 of the 16 factors compared between the two stocks.

Get Owlet News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OWLT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OWLT vs. The Competition

Export

Metric	Owlet	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$151.95M	$6.02B	$7.37B	$24.30B
Dividend Yield	N/A	1.75%	2.53%	3.70%
P/E Ratio	-6.97	26.67	272.88	30.31
Price / Sales	1.45	45.38	618.96	19.89
Price / Cash	N/A	33.24	78.62	32.49
Price / Book	6.62	6.23	13.05	6.77
Net Income	-$39.68M	$150.07M	$3.47B	$1.07B
7 Day Performance	-22.31%	0.69%	2.09%	-0.65%
1 Month Performance	0.48%	8.91%	6.64%	3.38%
1 Year Performance	-30.45%	8.07%	25.02%	14.90%

Owlet Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
OWLT Owlet	3.2241 of 5 stars	$5.23 -6.3%	$15.00 +186.8%	-30.5%	$151.95M	$105.70M	N/A	106	News Coverage
BWAY Brainsway	4.3825 of 5 stars	$14.98 -2.2%	$15.67 +4.6%	+93.9%	$614.81M	$56.22M	42.80	120	Analyst Downgrade
KIDS OrthoPediatrics	2.3044 of 5 stars	$24.24 +4.1%	$25.89 +6.8%	+27.0%	$607.84M	$236.35M	N/A	200	Analyst Forecast
DCTH Delcath Systems	2.8713 of 5 stars	$17.22 +3.3%	$23.17 +34.5%	+54.1%	$597.52M	$95.42M	1,723.72	60	Analyst Downgrade High Trading Volume
NPCE NeuroPace	3.9557 of 5 stars	$15.03 +1.0%	$19.29 +28.3%	+56.1%	$507.32M	$99.99M	N/A	170	News Coverage Analyst Revision

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:OWLT) was last updated on 8/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Owlet (OWLT) Competitors

OWLT vs. BWAY, KIDS, DCTH, NPCE, and CLPT

How does Owlet compare to Brainsway?

Summary

How does Owlet compare to OrthoPediatrics?

Summary

How does Owlet compare to Delcath Systems?

Summary

How does Owlet compare to NeuroPace?

Summary

How does Owlet compare to ClearPoint Neuro?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OWLT vs. The Competition

Owlet Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Owlet (OWLT) Competitors

OWLT vs. BWAY, KIDS, DCTH, NPCE, and CLPT

How does Owlet compare to Brainsway?

Does the media prefer OWLT or BWAY?

Do institutionals and insiders have more ownership in OWLT or BWAY?

Which has more risk and volatility, OWLT or BWAY?

Is OWLT or BWAY more profitable?

Which has better valuation and earnings, OWLT or BWAY?

Do analysts recommend OWLT or BWAY?

Summary

How does Owlet compare to OrthoPediatrics?

Which has better earnings and valuation, KIDS or OWLT?

Does the media refer more to KIDS or OWLT?

Do insiders & institutionals hold more shares of KIDS or OWLT?

Which has more risk & volatility, KIDS or OWLT?

Do analysts prefer KIDS or OWLT?

Is KIDS or OWLT more profitable?

Summary

How does Owlet compare to Delcath Systems?

Is DCTH or OWLT more profitable?

Which has more volatility and risk, DCTH or OWLT?

Does the media favor DCTH or OWLT?

Do analysts rate DCTH or OWLT?

Which has better valuation and earnings, DCTH or OWLT?

Do insiders & institutionals hold more shares of DCTH or OWLT?

Summary

How does Owlet compare to NeuroPace?

Do insiders & institutionals believe in NPCE or OWLT?

Does the media prefer NPCE or OWLT?

Which has higher valuation and earnings, NPCE or OWLT?

Do analysts rate NPCE or OWLT?

Which has more volatility and risk, NPCE or OWLT?

Is NPCE or OWLT more profitable?

Summary

How does Owlet compare to ClearPoint Neuro?

Does the media refer more to OWLT or CLPT?

Which has more risk and volatility, OWLT or CLPT?

Do analysts rate OWLT or CLPT?

Which has preferable valuation & earnings, OWLT or CLPT?

Do insiders & institutionals hold more shares of OWLT or CLPT?

Is OWLT or CLPT more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OWLT vs. The Competition

Owlet Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools